Document is current
Any future updates will be listed below
-
Authors
Chopra, Nipun
Wang, Ruizhi
Maloney, Bryan http://orcid.org/0000-0003-2364-9649
Nho, Kwangsik
Beck, John S.
Pourshafie, Naemeh
Niculescu, Alexander
Saykin, Andrew J. http://orcid.org/0000-0002-1376-8532
Rinaldi, Carlo
Counts, Scott E.
Lahiri, Debomoy K. http://orcid.org/0000-0002-1664-5933
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG051086,, R21AG4687100, P30AG010133)
U.S. Department of Health & Human Services | NIH | National Institute on Aging
U.S. Department of Health & Human Services | NIH | National Institute on Aging
- License Information
-
More Information
Article History
Received: 17 August 2019
Revised: 9 November 2019
Accepted: 13 November 2019
First Online: 15 January 2020
Compliance with ethical standards
:
: DKL is a member of the advisory boards for Entia Biosciences, and Provaidya LLC. He also has stock options from QR Pharma, and has patents or patents pending on AIT-082, Memantine, Acamprosate, and GILZ analogs. These play no role to influence the submitted work. The other authors declare that they have no conflict of interest.
: All procedures were approved and overseen by the Institutional Biosafety Committee (IBC), Office of Research Compliance, Indiana University, and Indianapolis, Indiana, USA. The animal study was carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and was approved by the National Institute of Neurological Disorders and Stroke Animal Care Committee. All experiments were conducted blindly by third party concealment of treatments with individually uniquely coded vials.
